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STATE-OF-THE-ART PAPERDSTATE-OF-THE-ART PAPER969Adjunctive Therapies to Limit Myocardial Infarction SizePaul Z. Gerczuk, Robert A. Kloner
Gerczuk and Kloner review the pathophysiology as well as several methods of cardioprotection to
prevent myocardial cell death during the time of ischemia and reperfusion. Interventional
techniques to mimic the benefit of ischemic pre-conditioning may be produced by
ischemic post-conditioning; provoking remote ischemia in the leg muscles with a blood
pressure cuff was shown to reduce myocardial infarction size. Lowering core body
temperature appears to be effective, at least in certain circumstances. Pharmaceutical
cardioprotective agents including adenosine, atrial natriuretic peptide, and cyclosporine
have all been shown to be at least somewhat effective, though the exact role for each
remains unknown.CLINICAL RESEARCH CLINICAL TRIALS
979ietary Intervention Prevents Dyslipidemia
Associated With Highly Active Antiretroviral TherapyRosmeri K. Lazzaretti, Regina Kuhmmer, Eduardo Sprinz, Carı´si A. Polanczyk, Jorge P. Ribeiro
Though the mechanisms are not well understood, the use of highly active antiretroviral
therapy (HAART), often results in weight gain, fat re-distribution, obesity and dyslipidemia,
characterized by hypertriglyceridemia and/or hypercholesterolemia. Lazzaretti and colleagues
randomized HAART naive patients to either a dietary intervention or a control group prior
to the initiation of HAART. In the dietary intervention group, advice based on the National
Cholesterol Education Program, was given every 3 months. Plasma cholesterol and low-
density lipoprotein (LDL)-cholesterol levels increased in the control group, but were
unchanged in the diet group. After 1 year of follow-up, 21% of patients who received dietary
counseling had a lipid profile compatible with dyslipidemia compared to 68% of the control
group.
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991hronic Total Occlusions Seen in 1 of 5 of Patients
With CAD Undergoing AngiographyPaul Fefer, Merril L. Knudtson, Asim N. Cheema, P. Diane Galbraith, Azriel B. Osherov, Sergey Yalonetsky,
Sharon Gannot, Michelle Samuel, Max Weisbrod, Daniel Bierstone, John D. Sparkes, Graham A. Wright,
Bradley H. Strauss
Fefer and colleagues used data from consecutive coronary angiography patients at 3
Canadian sites to determine the prevalence, clinical characteristics, and treatment
decisions in patients with chronic total occlusions (CTO). Excluding those with
previous coronary artery bypass graft surgery (CABG) or presenting with STEMI, a
CTO was found in 18% of patients with significant coronary artery disease. A
previous history of myocardial infarction was documented in 40% of study patients,
but there was ECG evidence of Q waves corresponding to the CTO artery territory
in only 26% of cases. Almost half the patients with CTO were treated medically, 25%
underwent CABG, and percutaneous coronary intervention (PCI) was done in 30% of
patients, although CTO lesions were attempted in only 10% of patients. These results
show that CTOs are common and the varying rates of attempted PCI of the CTO
highlight the need for prospective studies to determine the optimal strategy.HEART FAILURE
998mpact of Noncardiac Comorbidities on Morbidity and Mortality in
Patients With Heart Failure and Preserved Versus Reduced Ejection FractionSameer Ather, Wenyaw Chan, Biykem Bozkurt, David Aguilar, Kumudha Ramasubbu, Amit A. Zachariah,
Xander H. T. Wehrens, Anita Deswal
Ather and colleagues evaluated the prevalence and prognostic impact of non-cardiac
comorbidities in patients with heart failure (HF) using data from the Veterans Affairs
Medical System. Compared to patients with heart failure with reduced ejection fraction
(HFrEF), those with heart failure with preserved ejection fraction (HfpEF) were older and
had a higher prevalence of chronic obstructive pulmonary disease, diabetes, hypertension,
psychiatric disorders, anemia, obesity, peptic ulcer disease, and cancer. HFpEF patients had
lower HF hospitalization and higher non-HF hospitalization resulting in similar overall
hospitalization rates.
Editorial Comment: Dalane W. Kitzman, p. 1006(continued on page A-34)
MARCH 13, 2012 (continued) A-34g
t
a
m
s
c
t
a
EHEART FAILURE
1008Cardiac Fibrosis in Transplanted Hearts Is
Mainly Driven by Cells Derived From the DonorMartin Pichler, Peter P. Rainer, Silvia Schauer, Gerald Hoefler
Pichler and colleagues sought to determine if the collagen that causes myocardial fibrosis in
transplanted hearts is produced by cells from the donor or the recipient. Endomyocardial
biopsies from 7 sex-mismatched (female donor heart to a male recipient) heart transplant
recipients were studied. The results suggest that in humans the cardiac fibrosis of chronic
allograft rejection or scar formation provoked by mechanical trauma, is mainly driven by
fibroblasts present in the donor heart at the time of explant.HEART RHYTHM DISORDERS1017Epistatic Effects of Potassium Channel Genetic Variation on Atrial Fibrillation RiskStefan A. Mann, Robyn Otway, Guanglan Guo, Magdalena Soka, Lina Karlsdotter, Gunjan Trivedi,
Monique Ohanian, Poonam Zodgekar, Robert A. Smith, Merridee A. Wouters, Rajesh Subbiah, Bruce Walker,
Dennis Kuchar, Prashanthan Sanders, Lyn Griffiths, Jamie I. Vandenberg, Diane Fatkin
K channels play a major role in atrial repolarization but single mutations in K channel
enes alone do not seem to cause atrial fibrillation (AF). Mann and colleagues investigated
he effect of combinations of K channel variants in AF probands by sequencing the genes
nd characterizing the variants using patch-clamp techniques and in silico modeling. The
ajority of K channel variants had modest functional effects, but in silico modeling
uggested that combinations of variants produced nonlinear interactions with substantial
hanges in action potential duration and dispersion of repolarization. These results suggest
hat combinations of functional K channel gene variants may contribute to an atrial
rrhythmogenic substrate.ditorial Comment: Dawood Darbar, Babar Parvez, Robert Abraham, p. 1026ATHLETE’S HEART1029Frequency of Abnormal ECGs in Athletes May Vary by Country of OriginFernando M. Di Paolo, Christian Schmied, Yacine A. Zerguini, Astrid Junge, Filippo Quattrini,
Franco Culasso, Jiri Dvorak, Antonio Pelliccia
Recent observations in African athletes suggest high rates of left ventricular hypertrophy and
electrocardiogram (ECG) abnormalities. Di Paolo and colleagues sought to define the
electrocardiographic and echocardiographic characteristics of adolescent African athletes using
players participating in a Under-17 Championship. The African players were compared to
similar Italian athletes. A large proportion of the African athletes had ECG abnormalities,
including a striking increase in R/S-wave voltage, ST-segment elevation, and deeply inverted
or diffusely flat T waves. These findings suggest important genetic differences in the cardiac
response to intensive athletic activity.
